Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Chao Shan
Affiliation
Wuhan Institute of Virology, Chinese Academy of Sciences
ORCID
Career Start Year
2012
Papers
84
H Index
36
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37010428
Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant.
mBio
2023
37993332
Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants.
Sci Bull (Beijing)
2023
35279412
Infection and pathogenesis of the Delta variant of SARS-CoV-2 in Rhesus macaque.
Virol Sin
2022
35604772
mRNA based vaccines provide broad protection against different SARS-CoV-2 variants of concern.
Emerg Microbes Infect
2022
35659605
Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice.
Virol Sin
2022
36444358
Japanese Encephalitis Vaccine Generates Cross-Reactive Memory T Cell Responses to Zika Virus in Humans.
J Trop Med
2022
36726759
Single-dose AAV-based vaccine induces a high level of neutralizing antibodies against SARS-CoV-2 in rhesus macaques.
Protein Cell
2022
36374663
SARS-CoV-2 infection induces testicular injury in Rhesus macaque.
Virol Sin
2022
36371432
A potent, broadly protective vaccine against SARS-CoV-2 variants of concern.
NPJ Vaccines
2022
36224200
RNF185 regulates proteostasis in Ebolavirus infection by crosstalk between the calnexin cycle, ERAD, and reticulophagy.
Nat Commun
2022
33232299
Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade.
JCI Insight
2021
33657175
Inhibition of innate immune response ameliorates Zika virus-induced neurogenesis deficit in human neural stem cells.
PLoS Negl Trop Dis
2021
33597526
A genetically stable Zika virus vaccine candidate protects mice against virus infection and vertical transmission.
NPJ Vaccines
2021
33848289
Correction: Role of microglia in the dissemination of Zika virus from mother to fetal brain.
PLoS Negl Trop Dis
2021
33835391
Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates.
Virol Sin
2021
33500409
Role of mutational reversions and fitness restoration in Zika virus spread to the Americas.
Nat Commun
2021
34493710
RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates.
Cell Discov
2021
34620704
A mutation-mediated evolutionary adaptation of Zika virus in mosquito and mammalian host.
Proc Natl Acad Sci U S A
2021
34097570
A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351.
MAbs
2021
34034828
Zika virus induces neuronal and vascular degeneration in developing mouse retina.
Acta Neuropathol Commun
2021
33976198
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes.
Nat Commun
2021
34357990
Reporter Virus Neutralization Test Evaluation for Dengue and Zika Virus Diagnosis in Flavivirus Endemic Area.
Pathogens
2021
33420426
AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells.
Cell Res
2021
32511318
Topoisomerase III-ÿ is required for efficient replication of positive-sense RNA viruses.
bioRxiv
2020
33188207
Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys.
Nat Commun
2020
33241728
Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models.
Emerg Microbes Infect
2020
32747564
A Zika virus envelope mutation preceding the 2015 epidemic enhances virulence and fitness for transmission.
Proc Natl Acad Sci U S A
2020
32636454
Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.
Cell Res
2020
32826924
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques.
Nat Commun
2020
32628667
Role of microglia in the dissemination of Zika virus from mother to fetal brain.
PLoS Negl Trop Dis
2020
32641828
Envelope protein ubiquitination drives entry and pathogenesis of Zika virus.
Nature
2020
32419649
Zika structural genes determine the virulence of African and Asian lineages.
Emerg Microbes Infect
2020
32554698
Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection.
J Virol
2020
32544190
Peli1 signaling blockade attenuates congenital zika syndrome.
PLoS Pathog
2020
32516571
Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2.
Cell
2020
32260110
Using Next Generation Sequencing to Study the Genetic Diversity of Candidate Live Attenuated Zika Vaccines.
Vaccines (Basel)
2020
32454512
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2.
Nature
2020
30958095
Genetic and biochemical characterizations of Zika virus NS2A protein.
Emerg Microbes Infect
2019
31815005
An attenuated Zika virus NS4B protein mutant is a potent inducer of antiviral immune responses.
NPJ Vaccines
2019
31831806
Maternal vaccination and protective immunity against Zika virus vertical transmission.
Nat Commun
2019
31536610
Molecular basis of dengue virus serotype 2 morphological switch from 29°C to 37°C.
PLoS Pathog
2019
30940705
Erratum for Chen et al., "Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate".
mBio
2019
29298302
Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants.
PLoS One
2018
30076287
A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein.
Nat Commun
2018
29903417
Did Zika Virus Mutate to Cause Severe Outbreaks?
Trends Microbiol
2018
30228241
Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate.
mBio
2018
30201444
A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity.
EBioMedicine
2018
30008291
Zika Virus Vaccine: Progress and Challenges.
Cell Host Microbe
2018
30111567
Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach.
J Virol
2018
30247157
Peli1 facilitates virus replication and promotes neuroinflammation during West Nile virus infection.
J Clin Invest
2018
1 - 50 of 84
Column Actions
Search
Recommended Authors
Horacio M Pallar??s
Fundacion Instituto Leloir-CONICET
Career Start Year
2017
Number of shared co-authors
3
Thomas Vallet
Institut Pasteur, Center for the Viral Populations and Pathogenesis
Career Start Year
2017
Number of shared co-authors
2
James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year
2017
Number of shared co-authors
6
Brian E Dawes
University of Texas Medical Branch, 301 University Boulevard
Career Start Year
2016
Number of shared co-authors
5
Mir M Khalid
Gladstone Institutes
Career Start Year
2016
Number of shared co-authors
3
Kathleen M Voss
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year
2016
Number of shared co-authors
3
Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year
2015
Number of shared co-authors
2
Chengjin Ye
Texas Biomedical Research Institute
Career Start Year
2013
Number of shared co-authors
2
Nathan D Grubaugh
Yale School of Public Health
Career Start Year
2013
Number of shared co-authors
0
Giuditta De Lorenzo
MRC-University of Glasgow Centre for Virus Research
Career Start Year
2012
Number of shared co-authors
1
Maxime Chazal
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year
2012
Number of shared co-authors
2
Shashank Tripathi
Indian Institute of Science
Career Start Year
2011
Number of shared co-authors
7
Vinod R M T Balasubramaniam
Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia
Career Start Year
2011
Number of shared co-authors
2
James Zengel
Stanford University School of Medicine
Career Start Year
2010
Number of shared co-authors
5
Brett E Pickett
Brigham Young University
Career Start Year
2009
Number of shared co-authors
2
Velmurugan Balaraman
College of Veterinary Medicine, Kansas State University
Career Start Year
2009
Number of shared co-authors
1
Clayton R Morrison
University of North Carolina School of Medicine
Career Start Year
2008
Number of shared co-authors
3
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year
2008
Number of shared co-authors
1
Koen Bartholomeeusen
Institute of Tropical Medicine
Career Start Year
2007
Number of shared co-authors
2
Colm Atkins
Rutgers University
Career Start Year
2007
Number of shared co-authors
8
Jessica L Smith
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year
2005
Number of shared co-authors
0
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Career Start Year
2003
Number of shared co-authors
7
Kayvon Modjarrad
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year
2002
Number of shared co-authors
1
Marco Vignuzzi
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year
2001
Number of shared co-authors
2
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year
2001
Number of shared co-authors
6
Gary P Kobinger
University of Texas Medical Branch
Career Start Year
1997
Number of shared co-authors
7
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Career Start Year
1996
Number of shared co-authors
11
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year
1993
Number of shared co-authors
7
Alec J Hirsch
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year
1992
Number of shared co-authors
1
Mark T Heise
University of North Carolina at Chapel Hill.
Career Start Year
1990
Number of shared co-authors
6
row(s) 1 - 30 of 30
Collaborators
Pei-Yong Shi
University of Texas Medical Branch
Co-authored papers
61
Xuping Xie
University of Texas Medical Branch
Co-authored papers
30
Shannan L Rossi
Institute for Human Infection and Immunity, University of Texas Medical Branch
Co-authored papers
17
Hongjie Xia
University of Texas Medical Branch
Co-authored papers
9
Michael S Diamond
Washington University School of Medicine
Co-authored papers
5
Sasha R Azar
Houston Methodist Research Institute
Co-authored papers
4
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Co-authored papers
3
Ricardo Rajsbaum
University of Texas Medical Branch
Co-authored papers
3
Milan G Chheda
Co-authored papers
3
Zihe Rao
Nankai University
Co-authored papers
2
Steven G Widen
University of Texas Medical Branch
Co-authored papers
2
Adam Hage
University of Texas Medical Branch
Co-authored papers
2
Briana C Prager
Massachusetts General Hospital
Co-authored papers
2
Maria I Giraldo
University of Texas Medical Branch
Co-authored papers
2
Matthew J Gorman
Co-authored papers
2
Tianlei Xu
Emory University
Co-authored papers
1
Daisy W Leung
Washington University School of Medicine
Co-authored papers
1
Nanshan Zhong
Kunming University of Science and Technology
Co-authored papers
1
Veljko Veljkovic
Institute of Nuclear Sciences VINCA
Co-authored papers
1
Michael Woodson
University of Texas Medical Branch, 301 University Boulevard
Co-authored papers
1
David H O'Connor
Co-authored papers
1
Sarah van Tol
University of Texas Medical Branch
Co-authored papers
1
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers
1
Li Chen
Indiana University School of Medicine
Co-authored papers
1
Kristin L McNally
National Institute of Allergy and Infectious Diseases
Co-authored papers
1
Hideho Okada
Co-authored papers
1
Holly Ramage
Sidney Kimmel Medical College, Thomas Jefferson University
Co-authored papers
1
David I Watkins
Co-authored papers
1
Kenneth S Plante
University of Texas Medical Branch
Co-authored papers
1
Wendy Maury
Carver College of Medicine, University of Iowa
Co-authored papers
1
1 - 30